Anatomic Stage IIIC Breast Cancer AJCC v8 Clinical Trials

70 clinical trials for Anatomic Stage IIIC Breast Cancer AJCC v8 across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial — RECRUITING · PHASE3
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax — RECRUITING · PHASE1
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial — RECRUITING · PHASE3
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
• Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer — RECRUITING · PHASE1
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer — RECRUITING · PHASE2
• Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — RECRUITING · PHASE1
• Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING
• STEMVAC in Patients With Early Stage Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations — TERMINATED · PHASE2
• Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
• Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer — ACTIVE_NOT_RECRUITING
• Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer — TERMINATED · NA
• Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors — TERMINATED · NA
• A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment — TERMINATED · NA
• Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · NA
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE1
• Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer — ACTIVE_NOT_RECRUITING
• Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors — COMPLETED · PHASE1
• Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors — ACTIVE_NOT_RECRUITING · NA
• Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study — COMPLETED
• Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer — COMPLETED
• Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study — ACTIVE_NOT_RECRUITING · NA
• Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors — COMPLETED
• Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer — TERMINATED · PHASE2
• Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel — COMPLETED · PHASE2
• Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer — COMPLETED · PHASE1
• Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer — COMPLETED · NA
• T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer — COMPLETED · PHASE1
• Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial — COMPLETED · NA
• Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions — ACTIVE_NOT_RECRUITING · NA
• Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors — COMPLETED · NA
• Nipple Aspirate Fluid in Detecting Breast Cancer — COMPLETED · NA
• Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer — COMPLETED · PHASE1
• An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors — COMPLETED · NA
• Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer — COMPLETED · PHASE2
• Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer — WITHDRAWN · PHASE2
• M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer — COMPLETED · PHASE1
• Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer — COMPLETED · PHASE1
• Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy — TERMINATED · PHASE2
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer — COMPLETED · PHASE1
• A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer — OTHER · NA
• Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer — COMPLETED · PHASE1
• Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy — TERMINATED

Refine this search